While there is no direct evidence suggesting that semaglutide promotes cancer growth, the lack of specific studies on breast cancer patients means that caution is warranted
Remember, its always best to discuss any concerns with your healthcare provider, who can provide personalized advice based on your health history and specific needs
Address the Underlying Issue If the reason is addressable, work with your provider
Once that date passes, the medication should be discarded regardless of how much liquid remains
Get started No insurance required Personalized Care, 100% Online High-potency, 3rd Party lab tested Semaglutide reduces appetite, slows digestion, improves blood sugar control, Semaglutide is the active pharmaceutical ingredient (API) in FDA-approved Ozempic and Wegovy
The absence of immunogenicity signals further strengthens its clinical applicability